Handelsavisen
prelaunch
Companies ›Healthcare ›1789.HK
17
1789.HK — HKEX Medical Equipment, Supplies & Distribution

AK Medical Holdings Ltd

HK$6,07
Open in Charts → Attach watcher ⌖
— —
HKD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
—
P/E
—
EV / Rev
—
Div yield
1,87 %
Op margin
25,2 %
ROE
11,6 %
Net margin
22,9 %
Debt / equity
0,05
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
—
Open
—
Next earnings
—
Ex-dividend
—
TR 1Y
—
About

AK Medical Holdings Ltd provides medical equipment, supplies, and distribution services in the healthcare sector, generating revenue primarily through the sale and distribution of medical products.

Business. AK Medical Holdings Ltd (1789.HK) is a healthcare company engaged in the medical equipment, supplies, and distribution industry. The firm operates within the Healthcare Services & Equipment sector, focusing on product sales. It is primarily listed on the Hong Kong Stock Exchange. Specific details regarding operating segments and geographic presence are not provided.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
BUY8 analysts
8 buy0 hold0 sell
Avg 12m price target7,99

Analyst recommendations

8 analysts · consensus Buy
Buy8
Hold0
Sell0
12-month price target
7,99
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
—
not yet scored
Valuation
—
valuation pending
Analysts→
Buy
8 analysts · indicative
Ownership
—
not yet wired
Profitability→
11,6 %
return on equity
Quality
—
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 1789.

    • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 1789.HK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    AK Medical Holdings Ltd (1789.HK) is a healthcare company engaged in the medical equipment, supplies, and distribution industry. The firm operates within the Healthcare Services & Equipment sector, focusing on product sales. It is primarily listed on the Hong Kong Stock Exchange. Specific details regarding operating segments and geographic presence are not provided.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    The company maintains a strong liquidity position, with a current ratio of 4.1, indicating that it has sufficient short-term assets to cover its short-term liabilities. However, its net cash position is negative after subtracting total debt, which introduces a medium liquidity risk. The debt-to-equity ratio is low at 0.05, suggesting a conservative capital structure with minimal reliance on debt financing.

    Profitability metrics show a return on equity (ROE) of 11.64% and a return on assets (ROA) of 9.26%, both of which are strong indicators of efficient asset utilization and profitability. These figures are well above the typical thresholds for the medical equipment and supplies industry, suggesting that the company is outperforming its peers in terms of capital efficiency and earnings generation.

    The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification may expose the company to higher operational and market risks if demand in its primary market fluctuates.

    Looking ahead, the company is expected to maintain a stable growth trajectory, with no significant revenue growth or decline projected in the next fiscal year. The operating cash flow of 395.98 million CNY and free cash flow of 248.36 million CNY support the company's ability to fund operations and invest in future growth.

    The risk assessment indicates a low dilution potential, with no near-term pressure from share issuance or dilutive events. The company's capital structure remains stable, and there are no material risk factors related to dilution in the current financial statements. However, the negative net cash position after subtracting total debt is a key flag that may require monitoring in the coming periods.

    Recent filings and transcripts do not indicate any material events or strategic shifts that would significantly impact the company's operations or financial performance. Analysts have provided a generally positive outlook, with a mean recommendation of 1.75 (leaning toward "buy") and a mean price target of 7.99 CNY.

    Key takeaways
    • AK Medical Holdings Ltd has a strong liquidity position with a current ratio of 4.1, but a negative net cash position after debt raises medium liquidity risk.
    • The company's ROE of 11.64% and ROA of 9.26% indicate strong profitability and efficient use of capital.
    • Revenue is concentrated in a single business segment, with no material geographic diversification, increasing exposure to market-specific risks.
    • Analysts have a generally positive outlook, with a mean recommendation of 1.75 and a mean price target of 7.99 CNY.
    • The company has a low dilution risk, with no near-term pressure from share issuance or dilutive events.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    HK$6,07
    Market cap
    —
    Enterprise valueⓘ
    —
    P/Eⓘ
    —
    Non-GAAP P/Eⓘ
    —
    EV / Revenueⓘ
    —
    EV / Op incomeⓘ
    —
    EV / OCFⓘ
    —
    P / Bⓘ
    —
    P / Tangible bookⓘ
    —
    Tangible book
    HK$2.91B
    Net cashⓘ
    -HK$144.7M
    Current ratioⓘ
    4.1
    Debt / equityⓘ
    0.1
    ROAⓘ
    9.3%
    ROEⓘ
    11.6%
    Cash conversionⓘ
    117.0%
    CapEx / revenueⓘ
    -8.4%
    SBC / revenueⓘ
    —
    Dilution ratioⓘ
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    0,36
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    8
    Other metrics
    Revenue
    —
    no estimate
    Segment revenue
    —
    no estimate
    Margin
    —
    no estimate
    Segment margin
    —
    no estimate
    as of 2026-05-20 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPS—no estimate—no estimate0,36
    Revenue—no estimate—no estimate1,7B CNY
    Operating income—no estimate—no estimate437,0M CNY
    Full-year consensus mean (period as reported by source) · consensus in CNY. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution8 analysts
    Strong buy2
    Buy6
    Hold0
    Sell0
    Strong sell0
    12-month price targetHK$7,99 · Median HK$8,02
    Low HK$7,50High HK$8,41
    Operating income · consensus437,0M CNY
    EPS surprise
    −15,3 %
    reported vs consensus · miss
    Revenue surprise
    −14,2 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    LowHK$7,50
    MeanHK$7,99
    MedianHK$8,02
    HighHK$8,41
    SpotHK$6,07
    +31.5 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin25,2 %Above P75
    Net Margin22,9 %Above P75
    ROE11,6 %Above P75
    Capex / Rev-8,4 %Below median
    D/E0,05Above median
    Cash Conv1,17Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • AK Medical Holdings Ltd Market data — financials · 2026-05-26
    • AK Medical Holdings Ltd Market data — analyst estimates · 2026-05-26
    • AK Medical Holdings Ltd Market data — ESG · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    1789.HKCanonical
    HKEX · HKD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage